According to Fortune Business Insights, the global pharmaceutical packaging market size was valued at USD 116.58 billion in 2025. The market is projected to grow from USD 123.09 billion in 2026 to USD 201.69 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 6.37% during the forecast period of 2026–2034. North America dominated the market with a 29.97% share in 2025, supported by established pharmaceutical manufacturing, increasing healthcare expenditure, and strong demand for advanced drug packaging solutions.
The pharmaceutical packaging market encompasses primary, secondary, and tertiary packaging used throughout drug manufacturing, storage, transportation, and distribution. Primary packaging comes into direct contact with the medicine, while secondary packaging groups and protects individual products. Tertiary packaging supports bulk handling and transportation.
Plastic is the leading material because of its lightweight properties, versatility, durability, and cost-effectiveness. Bottles represent a major product category because they are widely used for tablets, capsules, syrups, and other oral medicines. Oral drug delivery packaging also accounts for a significant share because of the widespread use of tablets, capsules, powders, and liquid formulations.
However, manufacturers face challenges related to counterfeit medicines, strict regulatory requirements, material costs, and the environmental impact of packaging waste.
For detailed market insights: https://www.fortunebusinessinsights.com/pharmaceutical-packaging-market-102860
Sustainability is a major trend in pharmaceutical packaging. Manufacturers are developing recyclable materials, lightweight containers, paper-based alternatives, and packaging formats that reduce plastic consumption without compromising medicine protection.
In October 2024, Bayer introduced polyethylene terephthalate (PET) blister packaging for its Aleve brand in collaboration with Liveo Research. According to the source, the solution reduced the packaging's carbon footprint by 38% and eliminated the use of polyvinyl chloride (PVC).
Prefillable syringes, prefillable inhalers, cartridges, and specialized containers are gaining importance as pharmaceutical companies develop new treatment options. These systems can improve dosing convenience, reduce handling requirements, and help protect medicines from contamination.
The increasing use of injectable treatments and biologics is creating demand for packaging that maintains product integrity throughout storage and administration.
Serialization, digital tracking, and intelligent packaging technologies are gaining attention as manufacturers seek to improve supply chain visibility and reduce counterfeit risks. Sensors, RFID technologies, and other monitoring solutions can support product identification and, where applicable, help monitor storage conditions.
These innovations are becoming increasingly relevant as pharmaceutical supply chains become more complex.
Rising demand for medicines is a major driver of the pharmaceutical packaging market. Population growth, greater healthcare awareness, increasing chronic disease prevalence, and expanding access to treatment are encouraging pharmaceutical companies to increase production.
Higher manufacturing volumes create demand for bottles, blister packs, vials, closures, cartons, and protective transportation packaging.